Newsbenzinga
Ligand Pharmaceuticals Prices Upsized $625M 0.0% Convertible Senior Notes Offering Due 2031, Plans To Repurchase 228,859 Shares For $60M
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…